Study S003273

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study to Evaluate the Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin

ClinicalTrials.gov record

Registration

Registration: NCT01665352
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: COMPLETED
Enrollment: 186
Start: 2012-08
Primary completion: 2013-05
Lead sponsor: vTv Therapeutics
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:TTP054; DRUG:Placebo
Results posted: FALSE

Registered primary outcomes

Change from baseline in HbA1c (%) as compared to placebo [Day 1 to Day 84]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.